Effects of anti-tumour necrosis factor-alpha therapy on the quality of life in Crohn's disease.
van Balkom BP, Schoon EJ, Stockbrügger RW, Wolters FL, van Hogezand RA, van Deventer SJ, Oldenburg B, van Dullemen HM, Russel MG.
van Balkom BP, et al. Among authors: van deventer sj, van hogezand ra, van dullemen hm.
Aliment Pharmacol Ther. 2002 Jun;16(6):1101-7. doi: 10.1046/j.1365-2036.2002.01268.x.
Aliment Pharmacol Ther. 2002.
PMID: 12030951
Free article.
Clinical Trial.